OPKO Mexico is a pharmaceutical company engaged in the manufacture, marketing, and distribution of over 25 products, primarily in the generics market in Mexico. It has recently increased its focus on the development of proprietary products as well.
OPKO Mexico’s product line includes a wide variety of eye drops, including lubricants, antibiotics, and non-steroidal anti-inflammatory drugs.
In 2011, OPKO Mexico was awarded research grants by Mexico’s national technology and science council totaling over US $1 million.
Research areas include:
- Cervical cancer vaccine
- Commercial APIs
- Dengue fever
- Human influenza vaccine and other research on influenza
- Line of nutraceuticals and other natural products
- Uterine cancer vaccine
- West Nile virus